Apria Announces Pricing of Secondary Offering of Common Stock
11 Novembre 2021 - 3:37AM
Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced
today the pricing of a previously announced secondary offering of
4,500,000 shares of Apria common stock by a selling stockholder
affiliated with Blackstone at a price to the public of $31.50 per
share. The selling stockholder has also granted the underwriters a
30-day option to purchase up to 675,000 additional shares of common
stock. The offering is expected to close on November 15, 2021,
subject to customary closing conditions.
Apria is not offering any shares of its common
stock and will not receive any net proceeds from the sale of common
stock by the selling stockholder. Citigroup and Goldman Sachs &
Co. LLC are acting as joint lead book-running managers for the
offering. BofA Securities, UBS Investment Bank and Piper Sandler
are acting as joint book-running managers for the offering.
Citizens Capital Markets, Fifth Third Securities, TD Securities,
Academy Securities, Blaylock Van, LLC, Penserra Securities LLC and
Stern are acting as co-managers for the offering.
The offering of these securities is being made
only by means of a prospectus. When available, copies of the
preliminary prospectus and the prospectus relating to the offering
may be obtained from: Citigroup Global Markets Inc., c/o Broadridge
Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717,
by telephone at 1-800-831-9146 or by email at prospectus@citi.com;
Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200
West Street, New York, New York 10282, by telephone at
1-866-471-2526, by facsimile at 1-212-902-9316 or by email at
prospectus-ny@ny.email.gs.com; BofA Securities, Attention:
Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd
floor, Charlotte NC 28255-0001 or by email at
dg.prospectus_requests@bofa.com; or UBS Securities LLC, Attention:
Prospectus Department, 1285 Avenue of the Americas, New York, NY
10019, by telephone at (888) 827-7275 or by emailing
ol-prospectus-request@ubs.com; or Piper Sandler & Co.,
Attention: Prospectus Department, 800 Nicollet Mall, J12S03,
Minneapolis, Minnesota 55402, or by email at prospectus@psc.com or
by telephone at 1-800-747-3924.
A registration statement, including a prospectus,
which is preliminary and subject to completion, relating to these
securities has been filed with the Securities and Exchange
Commission (the “SEC”) and has become effective. This press release
shall not constitute an offer to sell or the solicitation of an
offer to buy, nor shall there be any sale of these securities in
any state or jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
About Apria
Apria is a leading provider of integrated home
healthcare equipment and related services in the United States,
providing home respiratory therapy, obstructive sleep apnea
treatment and negative pressure wound therapy. Its approximately
280 locations throughout the continental United States and Hawaii
serve nearly 2 million patients each year. All of Apria’s locations
are accredited by The Joint
Commission.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. These statements include any statements
regarding the proposed offering of Apria common stock and other
non-historical statements. Forward-looking statements include all
statements that do not relate solely to historical or current
facts. In some cases, you can identify these forward-looking
statements by the use of words such as “outlook,” “believes,”
“expects,” “potential,” “continues,” “may,” “will,” “should,”
“could,” “seeks,” “predicts,” “intends,” “trends,” “plans,”
“estimates,” “anticipates” or the negative version of these words
or other comparable words. Such forward-looking statements are
subject to various risks and uncertainties. Accordingly, there are
or will be important factors that could cause actual outcomes or
results to differ materially from those indicated in these
statements. These factors include but are not limited to those
described under “Risk Factors” in the Company’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2020 and in the
Company’s Quarterly Report on Form 10-Q for the three months ended
June 30, 2021, each as filed with the SEC, as such factors may be
updated from time to time in the Company’s periodic filings with
the SEC. These factors should not be construed as exhaustive and
should be read in conjunction with the other cautionary statements
that are included in this press release and in the Company’s
filings with the SEC. Investors are urged to consider carefully the
disclosure in the Company’s filings with the SEC, which are
accessible on the SEC’s website at www.sec.gov. The Company
undertakes no obligation to publicly update or review any
forward-looking statement, whether as a result of new information,
future developments or otherwise, except as required by law.
Investor Contacts
Kevin.Ellich@westwicke.com
Media Contacts
Mark.Corbae@westwicke.com
Kyle.Evans@westwicke.com
Grafico Azioni Apria (NASDAQ:APR)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Apria (NASDAQ:APR)
Storico
Da Mag 2023 a Mag 2024